Certara (CERT) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Jul, 2026Executive summary
FY 2025 revenue reached $418.8M, up 9% year-over-year, with adjusted EBITDA of $134.5M, up 10%.
Q4 2025 revenue was $103.6M, up 3% year-over-year; adjusted EBITDA was $32.5M, down 3%.
Net loss for Q4 2025 was $5.9M, compared to net income of $6.6M in Q4 2024; FY 2025 net income improved to ($1.6M) from ($12.1M) in FY 2024.
Jon Resnick was appointed CEO effective January 1, 2026, bringing over 30 years of experience.
Strategic priorities include focusing on core R&D technologies, accelerating AI integration, and enhancing customer engagement.
Financial highlights
FY 2025 revenue was $418.8M, up 9%; Q4 2025 revenue was $103.6M, up 3% year-over-year.
FY 2025 adjusted EBITDA was $134.5M (32% margin), up from $122M in 2024; Q4 adjusted EBITDA was $32.5M, down 3%.
FY 2025 adjusted net income was $70.9M; adjusted diluted EPS was $0.44.
Q4 software revenue grew 10% to $46.4M; full-year software revenue was $183.3M, up 18%.
Q4 services revenue was $57.3M, down 1% year-over-year; full-year services revenue was $235.6M, up 3%.
Outlook and guidance
FY 2026 revenue growth expected in the range of 0–4%.
Adjusted EBITDA margin projected at 30–32% for FY 2026, with margin lower in H1 and improving in H2.
Adjusted diluted EPS for FY 2026 expected between $0.44 and $0.48.
Q1 2026 expected at the low end of revenue range due to tough comparison; acceleration anticipated in later quarters.
Fully diluted shares forecasted at 160–162 million; tax rate expected at 30%.
Latest events from Certara
- Q1 2025 revenue up 10%, bookings up 12%, profitability returns, and $100M buyback announced.CERT
Q1 20258 Jul 2026 - Q1 revenue up 1% to $106.9M; net loss $8.8M; divestiture and AI initiatives advanced.CERT
Q1 20268 Jul 2026 - Strategic realignment and AI integration drive growth and innovation across clinical development.CERT
Jefferies Global Healthcare Conference 20263 Jun 2026 - AI-driven innovation, regulatory support, and market momentum set the stage for double-digit growth.CERT
RBC Capital Markets Global Healthcare Conference 202619 May 2026 - All proposals passed, including director elections and auditor ratification, in a virtual meeting.CERT
AGM 202615 May 2026 - Director elections, auditor ratification, and executive pay are key 2026 meeting topics.CERT
Proxy filing3 Apr 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.CERT
Proxy filing3 Apr 2026 - AI-driven product launches and disciplined cost control set the stage for cautious 2026 growth.CERT
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - 2026 guidance reflects stable markets, strong biosimulation growth, and operational transformation.CERT
Leerink Global Healthcare Conference 20269 Mar 2026